-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13%
692: Radiotherapy 1,207 0.01%
693: Chemotherapy 61,609 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14%
692: Radiotherapy 1,534 0.01%
693: Chemotherapy 61,552 0.44%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06%
690 … & neoplasms of uncertain behavior 6,509 0.08%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-ChangeLog-v20211-v20221.xlsx
October 01, 2021 - (v2022.1 vs v2021.1)
ICD-10-CM Code ICD-10-CM Code Description Comorbidity
Measure v2022.1
C563 Malignant … neoplasm of bilateral ovaries CANCER_SOLID
C7963 Secondary malignant neoplasm of bilateral ovaries
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
January 01, 1998 - cancer of skin 1307 0.02
24: Cancer of breast 23825 0.35
25: Cancer of uterus 7081 0.10
26: Cancer … 29: Cancer of prostate 17389 0.25
30: Cancer of testis 383 0.01
31: Cancer of other male genital … , other Unspecified primary 2048 0.03
42: Secondary malignancies 52242 0.77
43: Malignant neoplasm … 0.12
45: Maintenance chemotherapy, radiotherapy 37316 0.55
46: Benign neoplasm of uterus 44178 0.65 … 47: Other unspecified benign neoplasm 29162 0.43
48: Thyroid disorders 7118 0.10
49: Diabetes mellitus
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10B.PDF
January 01, 1999 - cancer of skin 128 0.02
24: Cancer of breast 2507 0.35
25: Cancer of uterus 815 0.11
26: Cancer of … : Cancer of prostate 2126 0.30
30: Cancer of testis 40 0.01
31: Cancer of other male genital organs … , other Unspecified primary 192 0.03
42: Secondary malignancies 5080 0.71
43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3650 0.51
46: Benign neoplasm of uterus 4972 0.69
47: Other … unspecified benign neoplasm 3463 0.48
48: Thyroid disorders 742 0.10
49: Diabetes mellitus without
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
January 01, 1998 - cancer of skin 149 0.02
24: Cancer of breast 2373 0.35
25: Cancer of uterus 692 0.10
26: Cancer of … : Cancer of prostate 1786 0.26
30: Cancer of testis 31 0.00
31: Cancer of other male genital organs … , other Unspecified primary 246 0.04
42: Secondary malignancies 5283 0.77
43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3740 0.55
46: Benign neoplasm of uterus 4354 0.64
47: Other … unspecified benign neoplasm 2870 0.42
48: Thyroid disorders 681 0.10
49: Diabetes mellitus without
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats.PDF
January 01, 1999 - cancer of skin 1315 0.02
24: Cancer of breast 24405 0.34
25: Cancer of uterus 7566 0.11
26: Cancer … 29: Cancer of prostate 20728 0.29
30: Cancer of testis 393 0.01
31: Cancer of other male genital … , other Unspecified primary 1858 0.03
42: Secondary malignancies 50461 0.70
43: Malignant neoplasm … 0.12
45: Maintenance chemotherapy, radiotherapy 36883 0.51
46: Benign neoplasm of uterus 48732 0.68 … 47: Other unspecified benign neoplasm 34867 0.48
48: Thyroid disorders 7555 0.10
49: Diabetes mellitus
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
January 01, 1999 - cancer of skin 150 0.02
24: Cancer of breast 2403 0.33
25: Cancer of uterus 755 0.10
26: Cancer of … : Cancer of prostate 2035 0.28
30: Cancer of testis 45 0.01
31: Cancer of other male genital organs … , other Unspecified primary 193 0.03
42: Secondary malignancies 5023 0.70
43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3634 0.50
46: Benign neoplasm of uterus 4924 0.68
47: Other … unspecified benign neoplasm 3469 0.48
48: Thyroid disorders 773 0.11
49: Diabetes mellitus without
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10A.PDF
January 01, 1998 - cancer of skin 122 0.02
24: Cancer of breast 2353 0.34
25: Cancer of uterus 753 0.11
26: Cancer of … : Cancer of prostate 1733 0.25
30: Cancer of testis 37 0.01
31: Cancer of other male genital organs … , other Unspecified primary 186 0.03
42: Secondary malignancies 5145 0.75
43: Malignant neoplasm without … 45: Maintenance chemotherapy, radiotherapy 3772 0.55
46: Benign neoplasm of uterus 4448 0.65
47: Other … unspecified benign neoplasm 2893 0.42
48: Thyroid disorders 715 0.10
49: Diabetes mellitus without
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - studies have
shown that prognosis can vary substantially.5-8 Brain metastases occur with a variety of
cancers … While treatment for brain metastases from other primary cancers
and in pediatric patients is equally … Epidemiology of metastatic brain tumors. … Effect of tumor subtype on survival and the
graded prognostic assessment for patients with breast cancer … OR cancer* OR neoplasm* OR
carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGsV20DefinitionsManual.pdf
January 13, 2015 - PROCS
172 172 DIGESTIVE MALIGNANCY
173 172 DIGESTIVE MALIGNANCY
174 174 G.I. … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
260 CDRG … PROC
366 366 MALIGNANCY, FEMALE REPRO SYSTEM
367 366 MALIGNANCY, FEMALE REPRO SYSTEM
368 368
-
hcup-us.ahrq.gov/db/nation/nis/APS-DRGs%20V21%20Definitions%20Manual.pdf
January 13, 2015 - PROCS
172 172 DIGESTIVE MALIGNANCY
173 172 DIGESTIVE MALIGNANCY
174 174 G.I. … PROC
202 205 DISORDERS OF LIVER, EX MALIGNANCY
203 203 MALIGNANCY OF HEPATOBIL SYST OR PANCREAS … 204 204 DISORDERS OF PANCREAS EXCEPT MALIGNANCY
205 205 DISORDERS OF LIVER, EX MALIGNANCY
206 205 … 258 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
259 CDRG EXCL 259 MASTECTOMY FOR MALIGNANCY
260 CDRG … PROC
366 366 MALIGNANCY, FEMALE REPRO SYSTEM
367 366 MALIGNANCY, FEMALE REPRO SYSTEM
368 368
-
hcup-us.ahrq.gov/reports/methods/2006_1.pdf
January 01, 2006 - For example, if a patient presents with a lump and it is
diagnosed as a malignant neoplasm during the … hospitalization, the malignant neoplasm should
be considered to be present on admission. … For example,
“personal history of malignant neoplasm” cannot develop after admission. … Neoplasm Bronchus or Lung 11,303 11,244 99.48 1,311 1,302 99.3%
174.9 Malignant Neoplasm Breast 4,735 … 4,724 99.77 960 952 99.2%
185 Malignant Neoplasm Prostate 14,486 14,438 99.67 4,855 4,781 98.5%
250.00
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/File1_AHCA_Presentation_To_AHSS_On_POA.jsp
August 01, 2011 - Final dx malignant neoplasm with metastasis.
-
effectivehealthcare.ahrq.gov/products/liver-cancer/research-protocol
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
November 08, 2017 - electrolyte
disorders 5,377,720 0 0.00 1.00 0.22 0.42
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06%
690 … & neoplasms of uncertain behavior 3,745 0.07%
710: Infectious & parasitic diseases including HIV w
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
January 01, 2014 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,071,762 0 0.00 1.00 0.11 0.31
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06%
690 … Percent
of Total
692: Radiotherapy 586 0.01%
693: Chemotherapy 29,695 0.42%
694: Lymphatic & other malignancies
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
January 01, 2012 - electrolyte
disorders 3,195,782 0 0.00 1.00 0.08 0.27
CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15%
110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG
APRDRG Frequency
Percent
of Total
693: Chemotherapy 32,305 1.01%
694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01%
710: Infectious & parasitic diseases including HIV w O.R
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
January 01, 2013 - Variable / Label
N
N
Miss Minimum Maximum Mean Std Dev
CM_METS : AHRQ comorbidity measure: Metastatic
cancer … measure: Renal
failure 7,119,563 0 0.00 1.00 0.10 0.30
CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08%
110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05%
681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06%
690 … Percent
of Total
692: Radiotherapy 664 0.01%
693: Chemotherapy 30,425 0.43%
694: Lymphatic & other malignancies